|
|
Volumn 97, Issue 5, 2005, Pages 332-
|
|
Multiple gene signatures aim to qualify risk in breast cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER GENETICS;
CANCER RECURRENCE;
CANCER SURVIVAL;
FEMALE;
HIGH RISK PATIENT;
HUMAN;
METASTASIS;
NOTE;
PRIORITY JOURNAL;
PROGNOSIS;
TISSUE MICROARRAY;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DNA FINGERPRINTING;
DNA MICROARRAY;
EPIDEMIOLOGY;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION;
GENETICS;
LYMPH NODE METASTASIS;
METHODOLOGY;
PATHOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REPRODUCIBILITY;
RISK;
RISK ASSESSMENT;
STANDARD;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENT;
DNA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIAS (EPIDEMIOLOGY);
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DNA FINGERPRINTING;
DNA, NEOPLASM;
FEMALE;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LYMPHATIC METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
ODDS RATIO;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PROGNOSIS;
PROSPECTIVE STUDIES;
RANDOMIZED CONTROLLED TRIALS;
REPRODUCIBILITY OF RESULTS;
RESEARCH DESIGN;
RISK ASSESSMENT;
|
|
EID: 20044394718
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/97.5.332 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|